DoD Research Programs Pre-Announces 2024 Funding Opportunities |
The Department of Defense Breast Cancer Research Program (BCRP) and Ovarian Cancer Research Program (OCPR) have both released a pre-announcements for the following funding opportunities:
|
Breast Cancer Research Program (BCRP) |
- Breakthrough Award Levels 1 and 2
- Breakthrough Award Level 3
-
Breakthrough Award Level 4
- Era of Hope Scholar Award
- Clinical Research Extension Award
- Transformative Breast Cancer Consortium Development Award
- Transformative Breast Cancer Consortium Award
|
Ovarian Cancer Research Program (OCRP) |
- Pilot Award
- Investigator-Initiated Research Award
- Clinical Trial Award
- Clinical Trial Translational Endpoints Award ** (NEW)
- Ovarian Cancer Academy – Leadership Award ** (NEW)
- Ovarian Cancer Academy – Early-Career Investigator Award
- Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award** (NEW)
|
|
|
January 16, 2024 | 12:00 p.m. to 1:00 p.m.
Leichtag Biomedical Research Building Room 107
|
Roger Tsien Cell Signaling San Diego Symposium |
January 17, 2024 | 11:00 a.m.
Scripps Seaside Forum
|
January 17, 2024 | 12:00 p.m.
Comer Commons
|
January 29, 2024 | 12:00 p.m.
Comer Commons
|
|
|
FEATURED FUNDING OPPORTUNITIES |
The Pediatric Cancer Research Foundation (PCRF) has three Limited Submission grant opportunities: Basic Science Research Grants (up to $150,000 per year, for up to 3 years), Translational Research Grants (up to $75,000 per year, for up to 2 years), and Emerging Investigator Fellowship Grants (up to $60,000 for one year). You can learn more about each of these three research grants here. LOIs are due to PCRF March 1, full proposals (based on approved LOI by PCRF) by June 1. If you are interested in being the MCC nominee for one of the above grants, please submit a 1-page Research Statement via InfoReady for review by our grants committee.
Internal Submission Deadline: February 2, 2024
|
The Network for Investigation of Delirium: Unifying Scientists (NIDUS) is awarding two $40,000 Pilot Awards for the 2024-2025 grant cycle. This cycle of Pilot Awards is focused on the inter-relationship of Delirium and Alzheimer’s Disease and Related Dementias (AD/ADRD).
Deadline: February 5, 2024
|
|
|
|
|
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons |
Journal of Clinical Oncology
|
William D. Roberts, MD (Hematologic Malignancies), Peter Zage (Structural and Functional Genomics)
|
|
|
| B3GALT6 promotes dormant breast cancer cell survival and recurrence by enabling heparan sulfate-mediated FGF signaling |
Jeffrey D. Esko, PhD (Solid Tumor Therapeutics)
|
|
|
|
|
Early Detection of Advanced Adenomas and Colorectal Carcinoma by Serum Glycoproteome Profiling |
Samir Gupta, MD (Cancer Control)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
D8531C00002: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Extended Therapy With Camizestrant Versus Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) in Patients With ER/HER2 Early Breast Cancer | PI: Angelique Richardson, MD, PhD
NCT: NCT05774951
|
PYX-106-101: A First-in-Human, Open-label, Multicenter, Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PYX106 in Subjects with Advanced Solid Tumors |
PI: Sandip Patel, MD
NCT: NCT05718557
|
DS1062-A-U104 (D926FC00001): A Phase 1b, Multicenter, 2Part, Open-Label Study of Datopotamab Deruxtecan (DatoDXd) in Combination With Immunotherapy With or Without Carboplatin in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (TropionLung04) |
PI: Sandip Patel, MD
NCT: NCT04612751
|
|
|
EQUITY, DIVERSITY, AND INCLUSION (EDI) |
Biomedical Engineering and Informatics Summer Research Internship Program |
|
|
This intensive summer research experience provides mentoring and research experiences focusing on Biomedical Engineering and Informatics research. We are committed to providing research opportunities to all students, with a special interest in applications from students typically underrepresented within the fields of science, technology, engineering, and mathematics. First-generation college attendees and those attending colleges with limited research opportunities in science, technology, engineering, and mathematics are also encouraged to apply.
Application Deadline: January 26, 2024
Visit Website for More Details
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT (COE) |
Join the Community Outreach & Engagement team for their first in-person CHEC mixer of the year on Wednesday, January 31st from 12-1:30pm at the Mission Hills-Hillcrest/Knox Library (215 W Washington St, San Diego, CA 92103) in their Community Room! Connect, network and share with community organizations! Light refreshments will be provided to attendees. For questions, contact the COE team at mcccoe@health.ucsd.edu. See you there!
|
Celebrate Cervical Cancer Awareness Month (CCAM) with us! Join the excitement as our Community Outreach & Engagement team hosts the 2nd annual Cervical Cancer Summit on January 29th from 1-2:30pm via Zoom. Stay engaged with a plethora of events and resources throughout the month and help spread awareness with our CCAM social media toolkit!
|
|
|
|
